Rua Bioscience’s first CBD product now prescribable
Produced at purpose-built Gisborne facility and distributed by CDC Pharmaceuticals.
NBR Staff Tue, 19 Apr 2022
NZX-listed medical cannabis firm Rua Bioscience has launched its first medicine, Rua CBD100, so registered medical practitioners are now able to prescribe it in patient treatment plans.
Rua is one of just two companies in New Zealand manufacturing medicinal cannabis that has met the minimum
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
